Search
Dexcom Inc
DXCMAdd to Watchlist
72.470USD
+1.240+1.74%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
27.97BMarket Cap
30.30P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Dexcom Inc is 8.50, ranking 28 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 84.20, with a high of 112.00 and a low of 68.00.
Analyst Rating
Based on
31
analysts
Buy
Current Rating
86.286
Target Price
+21.14%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Dexcom Inc
DXCM
31
Medtronic PLC
MDT
33
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
Medline Ord Shs Class A
MDLN
29
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Dexcom Inc's expected revenue for the next quarter?
Dexcom Inc's expected revenue is 1.29B.
What is Dexcom Inc's price target?
Analysts forecast that Dexcom Inc's price target is USD 84.20, with the highest forecast at USD 112.00 and the lowest forecast at USD 68.00.
How have Dexcom IncDXCM's recent earnings per share performed?
The market expectation was USD 0.52, while Dexcom IncDXCM's earnings per share (EPS) for the previous quarter was USD 0.69. EPS for the next quarter is expected at USD 0.61.
What is the analyst rating for Dexcom Inc?
Based on the ratings of Dexcom Inc's stock from 31 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
